2570
Recently, the Ukrainian Bar Association (UBA) Committee held a meeting on the topic ‘Ukrainian Bolar: efficiency and ways to improve’.
2805
The publishing house "Yuridychna Praktika" announced the twenty-first issue of Ukrainian Law Firms. A Handbook for Foreign Clients
3678
According to the results of the recently published international study The Legal 500 Europe, Middle East & Africa 2024 LA Law Firm is recognized among the leading law firms of Ukraine.
3250
The national ranking features three partners and a counsel across four practice categories. Managing partner Dmytro Aleshko named among the TOP 100 legal practitioners in Ukraine and leaders in Medical Law / Pharmaceuticals.
3156
The "Bolar Rule" is a provision that does not recognize as an infringement of a patent for an original medicinal product the actions taken by the applicant of a generic medicinal product (analogue of an original medicinal product) for the purpose of conducting trials and state registration of such medicinal product until the expiry of the patent.
3954
Leadership lessons for lawyers often focus on how to face up to tough times and take difficult decisions, but few managing partners will have had to square up to the challenges faced by Dmytro Aleshko since February 2022.
8523
The ranking study of the local market of legal services, published at the beginning of May by Yuridychna Gazeta covering 80 law firms
8257
Some aspects of protection of commercial secrets and actions of the company in relation to employees. - Yana Verhun, Daria Gulevska, LIGA:ZAKON BUSINESS, 28.09.2022
5374
On September 6-7, Legal Alliance law firm held a webinar dedicated to the new version of the Law of Ukraine "On Medicinal Products". Innovations in the field of intellectual property, in particular in the area of data exclusivity for the registration dossier, issues of parallel import, production, advertising and promotion of medicines were in focus.
10010
On August 18, 2022, the long-awaited new Law of Ukraine dated July 28, 2022 No. 2469-IX "On Medicinal Products" entered into force for the pharmaceutical sector. Over 150 pharma professionals joined Legal Alliance's webinar to analyse relevant legislative innovations and get an expert opinion on the restructuring of business processes taking into account the new requirements.
